Sphera Funds Management’s Applied Therapeutics APLT Stock Holding History

Sphera Funds Management’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,000	Closed	-$5K	–	99
2025 Q4	$5K	Hold	50,000	–	–	﹤0.01%	99
2025 Q3	$30.2K	Hold	50,000	–	–	0.01%	114
2025 Q2	$15.6K	Hold	50,000	–	–	﹤0.01%	110
2025 Q1	$24.4K	Hold	50,000	–	–	0.01%	114
2024 Q4	$42.8K	Sell	50,000 -261,572	-84%	-$1.64M	0.01%	106
2024 Q3	$2.65M	Sell	311,572 -362,696	-54%	-$2.14M	0.42%	67
2024 Q2	$3.15M	Buy	674,268 +55,239	+9%	+$261K	0.43%	65
2024 Q1	$4.21M	Buy	+619,029	New	+$2.78M	0.59%	55
2020 Q2	–	Sell	-67,967	Closed	-$2.22M	–	90
2020 Q1	$2.22M	Buy	+67,967	New	+$2.75M	0.28%	54

Sphera Funds Management's APLT Position: Q1 2026 in Review

Sphera Funds Management sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 50,000 shares — an estimated $5K sold.

Sphera Funds Management first reported a position in APLT in Q1 2020 and held it in 9 quarters. The position peaked at $4.21M in Q1 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Sphera Funds Management reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Sphera Funds Management sold 50,000 Applied Therapeutics shares in Q1 2026, an estimated $5K.
Sphera Funds Management first reported a position in Applied Therapeutics in Q1 2020 and held it in 9 quarters.
Sphera Funds Management's Applied Therapeutics position peaked at $4.21M in Q1 2024.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.